Our experimental models may provide a platform for identifying tumor-intrinsic vs. host-intrinsic differences in influencing the outcome of anti-tumor immunity in HNSCCs and for uncovering novel targets that may render tumor cells vulnerable to immune attack mediated by various populations including CD8, CD4 and PMN-MDSCs. The gene discussed is CD8A; the disease is neoplasm.